His primary scientific interests are in Virology, Mimivirus, Giant Virus, Mimiviridae and Marseilleviridae. Virus is the focus of his Virology research. Philippe Colson has included themes like Hydroxychloroquine, Coxiella burnetii, Doxycycline and Azithromycin in his Virus study.
Philippe Colson works mostly in the field of Mimivirus, limiting it down to concerns involving Acanthamoeba and, occasionally, Phylogenetics and Lineage. His studies examine the connections between Giant Virus and genetics, as well as such issues in Asfarviridae, with regards to Metagenomics. The Marseilleviridae study combines topics in areas such as Marseillevirus and Mamavirus.
Philippe Colson focuses on Virology, Giant Virus, Virus, Genetics and Genome. His Virology research is multidisciplinary, relying on both Severe acute respiratory syndrome coronavirus 2, Immunology and Genotype, Hepatitis E virus. His work carried out in the field of Hepatitis E virus brings together such families of science as Epidemiology, Hepatitis E, Zoonosis and Hepatitis.
His study looks at the intersection of Giant Virus and topics like Mimivirus with Acanthamoeba and Evolutionary biology. Philippe Colson is interested in Viral load, which is a field of Virus. His research brings together the fields of Hydroxychloroquine and Viral load.
His main research concerns Virology, Severe acute respiratory syndrome coronavirus 2, Coronavirus disease 2019, Genome and Internal medicine. His biological study spans a wide range of topics, including Reverse transcription polymerase chain reaction, Complementary DNA, DNA sequencing, Peripheral blood and Coronavirus. His Genome research includes elements of Virus, Clade and Genotype.
His Internal medicine study incorporates themes from Viral load and Azithromycin. His Azithromycin study combines topics from a wide range of disciplines, such as Young adult, Clinical trial and Viral shedding. His Hydroxychloroquine research includes themes of Observational study and Randomized controlled trial.
Philippe Colson spends much of his time researching Coronavirus disease 2019, Severe acute respiratory syndrome coronavirus 2, Hydroxychloroquine, Internal medicine and Virology. His Hydroxychloroquine research incorporates elements of Observational study, Randomized controlled trial, Virus, Pandemic and Azithromycin. His Virus study combines topics in areas such as Genome project and Genome.
His research integrates issues of Young adult and Clinical trial in his study of Azithromycin. His Internal medicine research integrates issues from Point of care, Point-of-care testing and Viral load. His study in Virology is interdisciplinary in nature, drawing from both DNA sequencing, Coronavirus and Pneumonia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
Philippe Gautret;Jean Christophe Lagier;Philippe Parola;Van Thuan Hoang.
International Journal of Antimicrobial Agents (2020)
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
Christian A. Devaux;Christian A. Devaux;Jean Marc Rolain;Philippe Colson;Didier Raoult.
International Journal of Antimicrobial Agents (2020)
Chloroquine and Hydroxychloroquine as Available Weapons to Fight COVID-19
Philippe Colson;Jean-Marc Rolain;Jean-Christophe Lagier;Philippe Brouqui.
International Journal of Antimicrobial Agents (2020)
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study.
Philippe Gautret;Jean Christophe Lagier;Philippe Parola;Van Thuan Hoang.
Travel Medicine and Infectious Disease (2020)
Pig liver sausage as a source of hepatitis E virus transmission to humans.
Philippe Colson;Patrick Borentain;Benjamin Queyriaux;Benjamin Queyriaux;Mamadou Kaba.
The Journal of Infectious Diseases (2010)
rpoB-Based Identification of Nonpigmented and Late-Pigmenting Rapidly Growing Mycobacteria
Toïdi Adékambi;Philippe Colson;Michel Drancourt.
Journal of Clinical Microbiology (2003)
Chloroquine for the 2019 novel coronavirus SARS-CoV-2.
Philippe Colson;Jean-Marc Rolain;Didier Raoult.
International Journal of Antimicrobial Agents (2020)
Chronic hepatitis E with cirrhosis in a kidney-transplant recipient.
René Gérolami;Valérie Moal;Philippe Colson.
The New England Journal of Medicine (2008)
Identification of Rare Pathogenic Bacteria in a Clinical Microbiology Laboratory: Impact of Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry
Piseth Seng;Cedric Abat;Jean Marc Rolain;Philippe Colson.
Journal of Clinical Microbiology (2013)
Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards.
Bernard La Scola;Marion Le Bideau;Julien Andreani;Van Thuan Hoang.
European Journal of Clinical Microbiology & Infectious Diseases (2020)
Aix-Marseille University
Aix-Marseille University
Aix-Marseille University
Aix-Marseille University
Aix-Marseille University
Aix-Marseille University
Aix-Marseille University
Centre national de la recherche scientifique, CNRS
Aix-Marseille University
Federal University of Toulouse Midi-Pyrénées
Inserm : Institut national de la santé et de la recherche médicale
Publications: 59
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: